ABOUT
TECHNOLOGY
PIPELINE
NEWS
CAREERS
CONTACT
中文 / En

Research and Development Pipeline

Drawing from our foundational innovations in iPSC technology, we bolster cell therapies with state-of-the-art technology to address unmet clinical needs. We aim to pioneer the emerging fields of tumor immunotherapy and regenerative medicine, setting new standards with the next generation of universal cell therapies.
  • Discovery
    Preclinical
    IND-enabling
    Clinical

  • Oncology

    ICA01

    Solid Tumors

    IIT Clinical
    Global
    IND-enablingIIT Clinical
    ICA01TB

    B Malignant Tumor Cells

    Validation in Animal Experiments
    Global
    IND-enablingValidation in Animal Experiments
    ICA2001

    Multiple Myeloma

    Preclinical Development
    Global
    DiscoveryPreclinical Development
    ICA3001

    Multiple Cancer Subtypes

    Preclinical Development
    Global
    IND-enablingPreclinical Development

  • Degenerative disease

    ICA03

    Osteoarthritis

    Australian Clinical Preparation
    Global
    PreclinicalAustralian Clinical Preparation
    ICA06

    Ophthalmic Diseases

    Differentiation technology development
    Global
    DiscoveryDifferentiation technology development
    ICA07

    Parkinson’s Disease

    Preclinical process development
    Global
    PreclinicalPreclinical process development
Copyright 2021 iCamumo. All Rights Reserved
苏ICP备2022047272号-1
  • E-mail
    info@icamuno.com
  • Telephone
    +86-0571-86956208